245 related articles for article (PubMed ID: 26787896)
1. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
Kinana AD; Vargiu AV; May T; Nikaido H
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
4. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.
Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H
Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133
[TBL] [Abstract][Full Text] [Related]
6. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
7. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
[TBL] [Abstract][Full Text] [Related]
8. Effect of site-directed mutations in multidrug efflux pump AcrB examined by quantitative efflux assays.
Kinana AD; Vargiu AV; Nikaido H
Biochem Biophys Res Commun; 2016 Nov; 480(4):552-557. PubMed ID: 27789287
[TBL] [Abstract][Full Text] [Related]
9. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.
Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R
J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069
[TBL] [Abstract][Full Text] [Related]
10. Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis.
Schuster S; Bohnert JA; Vavra M; Rossen JW; Kern WV
Molecules; 2019 Jan; 24(3):. PubMed ID: 30699887
[TBL] [Abstract][Full Text] [Related]
11. Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.
Kinana AD; Vargiu AV; Nikaido H
Biochemistry; 2013 Nov; 52(46):8342-51. PubMed ID: 24205856
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.
Malvacio I; Buonfiglio R; D'Atanasio N; Serra G; Bosin A; Di Giorgio FP; Ruggerone P; Ombrato R; Vargiu AV
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1397-1408. PubMed ID: 31075229
[TBL] [Abstract][Full Text] [Related]
13. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.
Vargiu AV; Nikaido H
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20637-42. PubMed ID: 23175790
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.
Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H
Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976
[TBL] [Abstract][Full Text] [Related]
15. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of RND multidrug efflux pumps.
Nikaido H; Takatsuka Y
Biochim Biophys Acta; 2009 May; 1794(5):769-81. PubMed ID: 19026770
[TBL] [Abstract][Full Text] [Related]
17. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
Lamers RP; Cavallari JF; Burrows LL
PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
[TBL] [Abstract][Full Text] [Related]
18. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
Misra R; Morrison KD; Cho HJ; Khuu T
J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
[TBL] [Abstract][Full Text] [Related]
19. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones.
Huguet A; Pensec J; Soumet C
J Appl Microbiol; 2013 May; 114(5):1294-9. PubMed ID: 23414263
[TBL] [Abstract][Full Text] [Related]
20. Drug transport mechanism of the AcrB efflux pump.
Pos KM
Biochim Biophys Acta; 2009 May; 1794(5):782-93. PubMed ID: 19166984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
